Dose requirements of hydralazine in patients with severe chronic congestive heart failure (Q71135770)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7355762%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Dose requirements of hydralazine in patients with severe chronic congestive heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7355762%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

congestive heart failure

1 reference

1 reference

M Packer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7355762%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

J Meller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7355762%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

N Medina

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7355762%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

R Gorlin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7355762%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

M V Herman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7355762%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

language of work or name

English

0 references

publication date

1 March 1980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7355762%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7355762%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7355762%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7355762%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

655-660

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7355762%20AND%20SRC:MED&resulttype=core&format=json

Oral hydralazine therapy for chronic refractory heart failure

16 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Hydralazine in the management of left ventricular failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Beneficial effects of hydralazine in severe mitral regurgitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Medical intelligence drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

CARDIAC NOREPHINEPHRINE STORES IN EXPERIMENTAL HEART FAILURE IN THE DOG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Alterations in the baroreceptor reflex in conscious dogs with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

THE SIGNIFICANCE OF THE STATE OF THE CENTRAL AUTONOMIC NERVOUS SYSTEM FOR QUANTITATIVE AND QUALITATIVE ASPECTS OF SOME CARDIOVASCULAR REACTIONS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Reduced drug elimination in congestive heart failure. Studies using aminopyrine as a model drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Hepatic drug-oxidizing enzyme systems and urinary D-glucaric acid excretion in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Hydralazine elimination in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Cardiocirculatory responses to muscular exercise in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

A Comparison of Regional Blood Flow and Oxygen Utilization During Dynamic Forearm Exercise in Normal Subjects and Patients with Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Vasodilator drugs in the treatment of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Resistance and sensitivity to digitalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Digitalis (third of four parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

The effect of congestive heart failure on quinidine pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Relation of hydralazine plasma concentration to dosage and hypotensive action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2880%2980019-1

10.1016/S0002-9149(80)80019-1

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7355762%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference